Spectrum Pharmaceuticals Inc
SPPI
SPPI was delisted on the 31st of July, 2023.
180 hedge funds and large institutions have $1.87B invested in Spectrum Pharmaceuticals Inc in 2018 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 73 increasing their positions, 41 reducing their positions, and 17 closing their positions.
118% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 17
94% more call options, than puts
Call options by funds: $20.1M | Put options by funds: $10.4M
78% more repeat investments, than reductions
Existing positions increased: 73 | Existing positions reduced: 41
42% more capital invested
Capital invested by funds: $1.32B → $1.87B (+$554M)
12% more funds holding
Funds holding: 161 → 180 (+19)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACA
Avoro Capital Advisors
New York
|
+$63.4M |
| 2 |
Primecap Management
Pasadena,
California
|
+$50.1M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$31.6M |
| 4 |
BlackRock
New York
|
+$27.1M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$22.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$38.2M |
| 2 |
Goldman Sachs
New York
|
-$25.6M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$24.1M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$24.1M |
| 5 |
Barclays
London,
United Kingdom
|
-$17.9M |
SPPI Hedge Fund Activity: Q2 2018 in Review
180 of the 4,385 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q2 2018, worth a combined $1.87B — up 42% from $1.32B a quarter earlier.
Buyers outnumbered sellers: 37 funds opened new SPPI positions and 17 closed out — a net gain of 20 holders — while 73 added to existing stakes and 41 trimmed.
The largest buyer was Avoro Capital Advisors, opening a new position worth an estimated $63.4M. The largest seller was Renaissance Technologies, cutting an estimated $38.2M.
- 180 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q2 2018, up from 161 in Q1 2018.
- Funds reported $1.87B of Spectrum Pharmaceuticals Inc stock for Q2 2018, up 42% quarter-over-quarter.
- 37 funds opened new Spectrum Pharmaceuticals Inc positions in Q2 2018 and 17 closed out, a net change of +20 holders.
- The largest Spectrum Pharmaceuticals Inc buyer in Q2 2018 was Avoro Capital Advisors, an estimated $63.4M added.
- The largest Spectrum Pharmaceuticals Inc seller in Q2 2018 was Renaissance Technologies, an estimated $38.2M sold.
Based on aggregated 13F filings for Q2 2018.